2ONE Labs Prevails in Trademark Dispute against IMB Zone Brand

Business by 2FIRSTS.ai
Dec.24.2024
2ONE Labs Prevails in Trademark Dispute against IMB Zone Brand
US nicotine pouch brand 2ONE Labs wins preliminary injunction in trademark dispute with Imperial Tobacco's Zone brand.

On December 23rd, the American nicotine pouch brand 2ONE Labs announced on its official website that the brand, in partnership with distributor Performance Plus Marketing, had achieved a favorable preliminary injunction (PI) ruling in a trademark dispute with the Imperial Tobacco brand Zone. According to a court order dated December 20th, 2024, Zone's nicotine pouches are prohibited from being shipped to trade partners in the United States.

 

The CEO of 2ONE Labs, Vincent Schuman, stated that

 

This ruling is significant as it prohibits Imperial Tobacco from continuing to sell Zone nicotine pouches in the United States until the ongoing 2ONE trademark lawsuit is resolved.

 

According to the judge's ruling, the defendant (Imperial) is prohibited from selling oral nicotine products with the Bullseye trademark or any similar symbol. (Case number: CV 24-08124-MWF(Ex) Title: 2ONE Labs Inc. et al v. ITG Brands, LLC et al)

 

We are pleased that the court has made the correct decision to approve this PI. This is an extraordinary remedy for 2ONE and sets the foundation for their victory in the trademark infringement lawsuit against Imperial Tobacco.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Research Summary | NHANES Study: Smoking or E-Cigarette Use Linked to Higher Prevalence of Elevated Blood Pressure and Hypertension
Research Summary | NHANES Study: Smoking or E-Cigarette Use Linked to Higher Prevalence of Elevated Blood Pressure and Hypertension
A cross-sectional analysis based on the US NHANES 2021–2023 cycle, including 6,262 participants aged over 12, found that compared with people who neither smoke nor vape, those who smoke and/or use e-cigarettes had a higher prevalence of elevated blood pressure and hypertension. After full adjustment, smoking/vaping was associated with elevated blood pressure (aOR 1.34) and hypertension (aOR 1.46), and with a 1.05 mmHg higher diastolic blood pressure.
Feb.09 by 2FIRSTS.ai
China Business Journal Reports: Multiple New E-Cigarette Policies Enter Public Consultation Phase in China, Covering Capacity Control and Credit Management
China Business Journal Reports: Multiple New E-Cigarette Policies Enter Public Consultation Phase in China, Covering Capacity Control and Credit Management
China Business Journal, citing a review of policy documents released by the State Tobacco Monopoly Administration in early 2026, said China’s latest e-cigarette rules target credit-based regulation, capacity controls and national standards revisions.Alan Zhao, co-founder of 2Firsts, said tighter oversight will speed consolidation, curb noncompliance and reduce destructive competition.
Jan.12 by 2FIRSTS.ai
Former Malaysian Health Minister Allegedly Rejected RM50 Million Bribe Over GEG
Former Malaysian Health Minister Allegedly Rejected RM50 Million Bribe Over GEG
A former political aide has alleged that a RM50 million bribe was offered to Malaysia’s then health minister to abandon the tobacco generational end game (GEG) policy. The claim was published in an opinion article and on social media. No report was made to anti-corruption authorities. Despite the alleged rejection, the GEG provision was later removed from the tobacco bill tabled in Parliament in 2023.
Dec.23 by 2FIRSTS.ai
West Virginia Bill Seeks to Replace Per-mL Vape Liquid Tax With 50% Sales-Price Tax
West Virginia Bill Seeks to Replace Per-mL Vape Liquid Tax With 50% Sales-Price Tax
West Virginia proposes tax rate adjustments on e-cigarette devices and e-liquids, with penalties for late reporting. Effective from July 1, 2026.
Feb.02 by 2FIRSTS.ai
Malaysia health minister says court conviction over vape promotion sets key precedent for Act 852 enforcement
Malaysia health minister says court conviction over vape promotion sets key precedent for Act 852 enforcement
Malaysia’s Health Minister Datuk Seri Dr Dzulkefly Ahmad said the Putrajaya Magistrate’s Court decision to convict a known personality for promoting vape has set an important legal precedent for enforcing the Control of Smoking Products for Public Health Act (Act 852).
Jan.09 by 2FIRSTS.ai
South Korean Court Strikes Down Health Levy on Vape Nicotine Liquids, Citing Disproportionate Penalties
South Korean Court Strikes Down Health Levy on Vape Nicotine Liquids, Citing Disproportionate Penalties
A Seoul court has annulled South Korea’s health-levy assessments imposed on multiple importers of nicotine liquids used for vaping. While the court agreed the nicotine could be treated as “tobacco” because it was found to be leaf-derived, it ruled the levy—stacked with other taxes and calculated on a blunt, volume-only basis—was so severe it effectively deprived businesses of the ability to operate, breaching constitutional proportionality and equality standards.
Jan.26 by 2FIRSTS.ai